Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Assembly Biosciences Inc.
DescriptionLive bacteria delivered to the gastrointestinal tract via the Gemicel oral delivery platform
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationClostridium
Indication DetailsTreat Clostridium difficile infection (CDI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today